Clinical trial
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell…
NCT00013533 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00013533 |
|---|---|
| Title | Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies |
| Official title | Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia, Myelodysplastic Syndrome, Non Hodgkin's Lymphoma, CML, ALL, AML, Lymphoma |
| Intervention type | Procedure |
| Interventions | Stem cell transplantation |
| Enrollment | 30 |
| Start date | Mar 14, 2001 |
| Primary completion | Mar 1, 2008 |
| Completion | May 7, 2015 |
| First posted | Mar 21, 2001 |
| Last update posted | Dec 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: